Stay updated on Pembrolizumab Combo in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Ovarian Cancer Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The site revision was updated from v3.6.0 to v3.6.3, indicating a deployment that likely includes fixes or minor improvements without changing the study content.
    Difference
    0.1%
    Check dated 2026-06-30T01:27:13.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    Change Detected
    Summary
    Added a recruitment status note 'No longer looking for participants' and new navigation/help sections ('How to Read a Study Record', 'Common Questions', 'How to Join a Study', 'Intervention/Treatment'). The revision footer updated from v3.5.5 to v3.6.0 to reflect the site update.
    Difference
    0.4%
    Check dated 2026-06-15T19:18:17.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.4 to v3.5.5, indicating a minor update to the page's revision metadata. The change does not modify visible content or functionality.
    Difference
    0.1%
    Check dated 2026-06-08T14:46:52.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    A Publications section was added to the study record, listing a Nat Commun article about the related pembrolizumab/DPX-Survivac/cyclophosphamide trial and noting that publications are automatically filled from PubMed (Revision: v3.5.4).
    Difference
    0.3%
    Check dated 2026-05-18T03:28:21.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    There are no textual changes listed for this page in the provided data.
    Difference
    0.1%
    Check dated 2026-05-10T21:53:37.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The page footer was updated from “Revision: v3.5.0” to “Revision: v3.5.3,” reflecting a new ClinicalTrials.gov site/record display revision without changing the study details.
    Difference
    0.1%
    Check dated 2026-04-26T08:24:06.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Ovarian Cancer Clinical Trial page.